Publications:

Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer.

Molecular And Cellular Endocrinology

Kastrati, Irida I; Semina, Svetlana S; Gordon, Benjamin B; Smart, Emily E

Publication Date: 2019-03-01

Variant appearance in text: HER2: S305A

PubMed Link: 30659843

Variant Present in the following documents:

• Main text

View BVdb publication page

Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Journal Of The National Cancer Institute

Barone, Ines I; Brusco, Lauren L; Gu, Guowei G; Selever, Jennifer J; Beyer, Amanda A; Covington, Kyle R KR; Tsimelzon, Anna A; Wang, Tao T; Hilsenbeck, Susan G SG; Chamness, Gary C GC; Andò, Sebastiano S; Fuqua, Suzanne A W SA

Publication Date: 2011-04-06

Variant appearance in text: ERBB2: S305A

PubMed Link: 21447808

Variant Present in the following documents:

• Main text

View BVdb publication page

Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity.

Oncogene

Barone, I I; Iacopetta, D D; Covington, K R KR; Cui, Y Y; Tsimelzon, A A; Beyer, A A; Andò, S S; Fuqua, S A W SA

Publication Date: 2010-04-22

Variant appearance in text: ERBB2: S305A

PubMed Link: 20101208

Variant Present in the following documents:

• Main text
• nihms-159832.pdf

View BVdb publication page